ANN ARBOR, MI – October 16, 2019 –

Ripple Science, a SaaS company accelerating clinical research, will attend the SaaS CXO summit in San Antonio, Texas. The SaaS CXO Summit is an opportunity for executives, venture capitalists, corporates, and sponsors to network, matchup and share best practices.

Ripple Science CEO Peter Falzon explains, “Attending the largest gathering of SaaS ecosystem participants in the Midwest further expands the opportunity for Ripple to achieve fundraising goals in less than the anticipated timeframe.”

Ripple Science is currently seeking a lead investor for a two-million-dollar seed round. The CXO Summit begins on October 22.

About Ripple Science: Ripple Science accelerates clinical research with its secure, HIPAA-compliant suite of tools. By adapting sales and marketing automation to the process of patient recruitment, Ripple helps our customers recruit more participants, faster and reduces patients lost to follow-up.

Ripple Science’s flagship product, Ripple, is currently being used by research investigators at more than 100 academic and research centers around the world, including Johns Hopkins University, Pennsylvania State University, University of California Los Angeles, the Brain Research Foundation Canada, University of East Anglia (UK), Cognito Therapeutics (Boston, MA) and the University of Michigan.